570 related articles for article (PubMed ID: 31141951)
21. [Genetic counselling is relevant in familial as well as sporadic cases of amyotrophic lateral sclerosis].
Lindquist SG; Dunø M; Svenstrup K; Nielsen JE
Ugeskr Laeger; 2014 Oct; 176(43):. PubMed ID: 25353674
[TBL] [Abstract][Full Text] [Related]
22. CRISPR/Cas9-Mediated Gene Correction to Understand ALS.
Yun Y; Ha Y
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471232
[TBL] [Abstract][Full Text] [Related]
23. Research progress on vesicular trafficking in amyotrophic lateral sclerosis.
Yang C; Zhang X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 51(3):380-387. PubMed ID: 36161717
[TBL] [Abstract][Full Text] [Related]
24. Common mutations of interest in the diagnosis of amyotrophic lateral sclerosis: how common are common mutations in ALS genes?
Perrone B; Conforti FL
Expert Rev Mol Diagn; 2020 Jul; 20(7):703-714. PubMed ID: 32497448
[TBL] [Abstract][Full Text] [Related]
25. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism.
Ferraiuolo L; Meyer K; Sherwood TW; Vick J; Likhite S; Frakes A; Miranda CJ; Braun L; Heath PR; Pineda R; Beattie CE; Shaw PJ; Askwith CC; McTigue D; Kaspar BK
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6496-E6505. PubMed ID: 27688759
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of the mutation spectrum in 301 German ALS families.
Müller K; Brenner D; Weydt P; Meyer T; Grehl T; Petri S; Grosskreutz J; Schuster J; Volk AE; Borck G; Kubisch C; Klopstock T; Zeller D; Jablonka S; Sendtner M; Klebe S; Knehr A; Günther K; Weis J; Claeys KG; Schrank B; Sperfeld AD; Hübers A; Otto M; Dorst J; Meitinger T; Strom TM; Andersen PM; Ludolph AC; Weishaupt JH;
J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):817-827. PubMed ID: 29650794
[TBL] [Abstract][Full Text] [Related]
27. Protein folding alterations in amyotrophic lateral sclerosis.
Parakh S; Atkin JD
Brain Res; 2016 Oct; 1648(Pt B):633-649. PubMed ID: 27064076
[TBL] [Abstract][Full Text] [Related]
28. Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS.
Cook C; Petrucelli L
Neuron; 2019 Mar; 101(6):1057-1069. PubMed ID: 30897357
[TBL] [Abstract][Full Text] [Related]
29. Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development.
Bowerman M; Murray LM; Scamps F; Schneider BL; Kothary R; Raoul C
Eur J Med Genet; 2018 Nov; 61(11):685-698. PubMed ID: 29313812
[TBL] [Abstract][Full Text] [Related]
30. Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis.
Goutman SA; Chen KS; Paez-Colasante X; Feldman EL
Handb Clin Neurol; 2018; 148():603-623. PubMed ID: 29478603
[TBL] [Abstract][Full Text] [Related]
31. Gene Therapy for ALS-A Perspective.
Cappella M; Ciotti C; Cohen-Tannoudji M; Biferi MG
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500113
[TBL] [Abstract][Full Text] [Related]
32. The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis.
Bose P; Tremblay E; Maios C; Narasimhan V; Armstrong GAB; Liao M; Parker JA; Robitaille R; Wen XY; Barden C; Drapeau P
Neurotherapeutics; 2019 Oct; 16(4):1149-1166. PubMed ID: 31342410
[TBL] [Abstract][Full Text] [Related]
33. Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy.
Bagyinszky E; Hulme J; An SSA
Cells; 2023 Jul; 12(15):. PubMed ID: 37566027
[TBL] [Abstract][Full Text] [Related]
34. Multiomic ALS signatures highlight subclusters and sex differences suggesting the MAPK pathway as therapeutic target.
Caldi Gomes L; Hänzelmann S; Hausmann F; Khatri R; Oller S; Parvaz M; Tzeplaeff L; Pasetto L; Gebelin M; Ebbing M; Holzapfel C; Columbro SF; Scozzari S; Knöferle J; Cordts I; Demleitner AF; Deschauer M; Dufke C; Sturm M; Zhou Q; Zelina P; Sudria-Lopez E; Haack TB; Streb S; Kuzma-Kozakiewicz M; Edbauer D; Pasterkamp RJ; Laczko E; Rehrauer H; Schlapbach R; Carapito C; Bonetto V; Bonn S; Lingor P
Nat Commun; 2024 Jun; 15(1):4893. PubMed ID: 38849340
[TBL] [Abstract][Full Text] [Related]
35. Motor neurons from ALS patients with mutations in C9ORF72 and SOD1 exhibit distinct transcriptional landscapes.
Wong CO; Venkatachalam K
Hum Mol Genet; 2019 Aug; 28(16):2799-2810. PubMed ID: 31107959
[TBL] [Abstract][Full Text] [Related]
36. RNA and Protein Interactors with TDP-43 in Human Spinal-Cord Lysates in Amyotrophic Lateral Sclerosis.
Volkening K; Keller BA; Leystra-Lantz C; Strong MJ
J Proteome Res; 2018 Apr; 17(4):1712-1729. PubMed ID: 29513014
[TBL] [Abstract][Full Text] [Related]
37. [Familial Amyotrophic Lateral Sclerosis].
Suzuki N; Nishiyama A; Kato M; Warita H; Aoki M
Brain Nerve; 2019 Nov; 71(11):1169-1181. PubMed ID: 31722303
[TBL] [Abstract][Full Text] [Related]
38. The epidemiology and genetics of Amyotrophic lateral sclerosis in China.
Liu X; He J; Gao FB; Gitler AD; Fan D
Brain Res; 2018 Aug; 1693(Pt A):121-126. PubMed ID: 29501653
[TBL] [Abstract][Full Text] [Related]
39. ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis.
Parakh S; Jagaraj CJ; Vidal M; Ragagnin AMG; Perri ER; Konopka A; Toth RP; Galper J; Blair IP; Thomas CJ; Walker AK; Yang S; Spencer DM; Atkin JD
Hum Mol Genet; 2018 Apr; 27(8):1311-1331. PubMed ID: 29409023
[TBL] [Abstract][Full Text] [Related]
40. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
